Spatiotemporal analysis of tumor uptake patterns in dynamic 18FDG-PET and dynamic contrast enhanced CT

Acta Oncologica

Volumn 50, Issue 6, 2011, Pages 873-882

  Malinen, Eirik ^a,b   Rødal, Jan ^a,c   Knudtsen, Ingerid Skjei ^d   Søvik, Åste ^a,e   Skogmo, Hege Kippenes ^e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODIXANOL; IOHEXOL; POLY(METHYL METHACRYLATE);

CELL HETEROGENEITY; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; DOG; DRUG UPTAKE; DYNAMIC CONTRAST ENHANCED COMPUTER ASSISTED TOMOGRAPHY; DYNAMIC POSITRON EMISSION TOMOGRAPHY; FEMALE; HEAD AND NECK TUMOR; HISTOLOGY; INTENSITY MODULATED RADIATION THERAPY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ANIMALS; CONTRAST MEDIA; DOGS; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79960533619     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.579161     Document Type: Conference Paper

References (31)

1. Tredan O, Galmarini CM, Patel K, Tannock IF. Drug resist-ance and the solid tumor microenvironment. J Natl Cancer Inst 2007;99:1441-54.
2. Glunde K, Pathak AP, Bhujwalla ZM. Molecular-functional imaging of cancer: To image and imagine. Trends Mol Med 2007;13:287-97. (Pubitemid 47017002)
3. Malinen E, Sovik A, Hristov D, Bruland OS, Olsen DR. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006;51:4903-21. (Pubitemid 44429851)
4. Sovik A, Malinen E, Olsen DR. Strategies for biologic image-guided dose escalation: A review. Int J Radiat Oncol Biol Phys 2009;73:650-8.
5. Sovik A, Malinen E, Olsen DR. Adapting biological feedback in radiotherapy. Semin Radiat Oncol 2010;20:138-46.
6. Thorwarth D, Alber M. Implementation of hypoxia imaging into treatment planning and delivery. Radiother Oncol 2010; 97:172-5.
7. Grau C, Olsen DR, Overgaard J, Hoyer M, Lindegaard JC, Muren LP. Biology-guided adaptive radiation therapy-presence or future? Acta Oncol 2010;49:884-7.
8. Lee TY, Purdie TG, Stewart, E. CT imaging of angiogenesis. Q J Nucl Med 2003;47:171-87. (Pubitemid 37279154)
9. Castell F, Cook GJ. Quantitative techniques in 18FDG PET scanning in oncology. Br J Cancer 2008;98:1597-601. (Pubitemid 351684676)
10. Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, et al. Biologic correlates of intratumoral heterogene-ity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:675-82. (Pubitemid 41716413)
11. Abramyuk A, Wolf G, Shakirin G, Haberland U, Tokalov S, Koch A, et al. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/ CT for outcome prediction in head and neck tumors. Acta Radiol 2010;51:793-9.
12. Rodal J, Sovik S, Skogmo HK, Knudtsen IS, Malinen E. Feasibility of contrast-enhanced cone-beam CT for target localization and treatment monitoring. Radiother Oncol 2010;97:521-4.
13. Sovik A. Rodal J, Skogmo HK, Lervag C, Eilertsen K, Malinen, E. Adaptive radiotherapy based on contrast enhanced cone beam CT imaging. Acta Oncol 2010;49:972-7.
14. Mullani NA, Herbst RS, O'Neil RG, Gould KL, Barron BJ, Abbruzzese JL. Tumor blood fl ow measured by PET dynamic imaging of fi rst-pass 18F-FDG uptake: A comparison with 15O-labeled water-measured blood fl ow. J Nucl Med 2008; 49:517-23. (Pubitemid 351520598)
15. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffus-able tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32. (Pubitemid 29463104)
16. Cao M, Liang Y, Shen C, Miller KD, Stantz, KM. Develop-ing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype. IEEE Trans Med Imaging 2009;28:861-71.
17. Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad, T. Diffusion-weighted magnetic resonance imaging for pretreat-ment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neo-adjuvant chemotherapy. Acta Oncol 2010;49:354-60.
18. Rodal J, Sovik A, Malinen E. Infl uence of MLC leaf width on biologically adapted IMRT plans. Acta Oncol 2010;49: 1116-23.
19. Petit SF, Dekker AL, Seigneuric R, Murrer L, van Riel NA, Nordsmark M, et al. Intra-voxel heterogeneity infl uences the dose prescription for dose-painting with radiotherapy: A modelling study. Phys Med Biol 2009;54:2179-96.
20. Konerding MA, Fait E, Gaumann A. 3D microvascular architecture of pre-cancerous lesions and invasive carcino-mas of the colon. Br J Cancer 2001;84:1354-62. (Pubitemid 32522104)
21. Paoloni M, Khanna, C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008;8:147-56. (Pubitemid 351161319)
22. Sovik A, Kippenes Skogmo H, Bruland OS, Rune Olsen D, Malinen E. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol 2008;47:1249-56.
23. Sovik S, Skogmo HK, Andersen EK, Bruland OS, Olsen DR, Malinen, E. DCEMRI of spontaneous canine tumors during fractionated radiotherapy: A pharmacokinetic analysis. Radiother Oncol 2009;93:618-24.
24. Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009;74:766-73.
25. Horsman MR, Nielsen T, Ostergaard L, Overgaard J. Radiation administered as a large single dose or in a fraction-ated schedule: Role of the tumour vasculature as a target for infl uencing response. Acta Oncol 2006;45:876-80. (Pubitemid 44423135)
26. Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759-67.
27. Hermans R, Meijerink M, Van den Bogaert W, Rijnders A, Weltens C, Lambin P. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351-6. (Pubitemid 37443976)
28. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007;8:63-74. (Pubitemid 44943092)
29. Newbold K, Castellano I, Charles-Edwards E, Mears D, Sohaib A, Leach M, et al. An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74:29-37.
30. Ellingsen C, Egeland TA, Gulliksrud K, Gaustad JV, Mathiesen, B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73:838-45.
31. Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes: A survey of image segmentation techniques. Eur J Nucl Med Mol Imaging 2010;37:2165-87.